Skip to content

Domestic endoscopic surgery robot system for gastrointestinal surgery clinical application solution —— "Domestic endoscopic surgery robot system for clinical application solution research" project topic two

Domestic endoscopic surgery robot system for gastrointestinal surgery clinical application solution —— "Domestic endoscopic surgery robot system for clinical application solution research" project topic two

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081721
Enrollment
Unknown
Registered
2024-03-11
Start date
2024-03-11
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive diseases

Interventions

Domestic Surgery Robot Group:Perform domestic surgery robotic surgery

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age = 18 years and age = 80 years, no gender restrictions. (2) Proposed minimally invasive gastric (gastric cancer, gastric mesenchymal tumor, etc.), colorectal (colon cancer, rectal cancer, etc.), and appendiceal (benign or malignant appendiceal disease) surgeries, among others: ? Patients with gastric cancer must meet primary gastric cancer stage I/II/III; ? Patients with gastric mesenchymal tumors must have no distant metastases; ? Patients with colorectal cancer must meet primary colorectal cancer stage I/II/III; ? Patients with appendiceal malignancies must have no distant metastases; (3) Patients fully understand the benefits and risks of the trial, are willing to participate in the trial, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Unable to tolerate surgery or anesthesia because of severe heart, lung, brain, liver, or kidney disease; (2) Unable to tolerate pneumoperitoneum; (3) Severe coagulation disorders; (4) Patients with active tuberculosis; (5) Patients with severe uncontrolled medical conditions or acute infectious diseases; (6) Inability to perform puncture to establish pneumoperitoneum due to risk of extensive and severe adhesions in the abdominal cavity, etc., as judged by the investigators; (7) Physical exhaustion, excessive ascites, internal bleeding, or shock; (8) Gastric cancer lymph node metastases fused and engulfed major blood vessels; (9) Colorectal cancer obstruction with marked abdominal distension; (10) Extensive tumor metastasis in the abdomen and pelvis; (11) Emergency surgery for acute tumor obstruction, perforation, bleeding, etc.; (12) Tumor perforation combined with acute peritonitis; (13) Pregnant and lactating women; (14) History of epilepsy, psychosis, or cognitive impairment; (15) Other conditions that the investigator deems unsuitable for this study.

Design outcomes

Primary

MeasureTime frame
Operation efficiency;

Secondary

MeasureTime frame
Complications incidence;Adverse event rate;

Countries

China

Contacts

Public ContactXian Shen

The First Affiliated Hospital of Wenzhou Medical University

13968888872@163.com+86 139 6888 8872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026